S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,600
+150 (0.44%)
At close: Apr 28, 2026

S.Biomedics Revenue

In the year 2025, S.Biomedics had annual revenue of 16.55B KRW with 20.49% growth. S.Biomedics had revenue of 4.03B in the quarter ending December 31, 2025, a decrease of -9.35%.

Revenue
16.55B
Revenue Growth
+20.49%
P/S Ratio
25.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
428.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.55B2.81B20.49%
Dec 31, 202413.73B625.65M4.77%
Dec 31, 202313.11B995.73M8.22%
Dec 31, 202212.11B3.24B36.58%
Dec 31, 20218.87B3.55B66.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HansBiomed 100.17B
Kangstem Biotech 3.57B
curacle co.,ltd. 7.10M
Y-Biologics 2.91B
TiumBio 12.29B
NIBEC 32.72B
IntoCell 2.30B
Bio Solution 15.20B
Revenue Rankings